Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Lansoprazole
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lansoprazole 60mg/5ml oral liquid
0103050L0AAALAL
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 7.5mg/5ml oral liquid
0103050L0AAANAN
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Lansoprazole 8mg/5ml oral suspension
0103050L0AABCBC
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | No data available |
|
Zoton 15mg gastro-resistant capsules
0103050L0BBABAB
|
Zoton | Lansoprazole | Gastro-Intestinal System | No data available |
|
Zoton 30mg gastro-resistant capsules
0103050L0BBAAAA
|
Zoton | Lansoprazole | Gastro-Intestinal System | No data available |
|
Zoton 30mg gastro-resistant granules sachets
0103050L0BBACAD
|
Zoton | Lansoprazole | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.